L. Maximilian Buja, MD

Dr. Buja is engaged in scholarly investigation, educational activities and clinical service while also serving in leadership roles. His subspecialty interest is cardiovascular pathology with research interests in myocardial cell injury, myocardial ischemia, atherosclerosis and cardiomyopathies. Dr. Buja teaches medical students, medical residents, clinical fellows, graduate students and research post-doctoral fellows.

Show full bio

He also conducts a clinical practice in cardiovascular pathology providing staffing of autopsy cases and surgical pathology consultation of cardiac and vascular cases and interpretation of myocardial biopsies from referrals. He directs a cardiovascular pathology fellowship approved by the Texas Medical Board. Since the establishment of an Advanced Heart Failure Center on campus, he has served as the cardiovascular pathologist for the Center and has provided staffing for over 100 heart transplants, numerous LVADs, and post-transplant myocardial biopsies for evaluation and grading of antibody-mediated and acute cellular rejection. Dr. Buja serves as a consultant in cardiovascular pathology for the Harris County Institute of Forensic Sciences. He serves as the Director of the DPALM Autopsy Service at the affiliated teaching hospitals and has been an advocate of the importance of the autopsy as a tool in medical research and quality control in healthcare. He is the editor-in-chief of Cardiovascular Pathology, the official journal of the Society for Cardiovascular Pathology. He also serves as the Executive Director of The Texas Medical Center Library located adjacent to the medical school.

See Publications

Texas Heart Institute Positions

  • Chief, Cardiovascular Pathology Research
  • Editorial Board, Texas Heart Institute Journal

Interests

  • Cardiovascular pathology
  • Atherosclerosis
  • Ischemic heart disease
  • Cardiomyopathies

Education

  • Undergraduate:

    Loyola University

  • Medical School:

    Tulane University School of Medicine

  • Internship:

    Charity Hospital in New Orleans

  • Residency:

    National Cancer Institute

  • Fellowships:

    National Cancer Institute

Academic & Clinical Affiliations

  • McGovern Medical School, University of Texas Health Science Center at Houston

Honors, Awards and Memberships

Publications

4862227 B3LYFWPU 1 alternatives-to-animal-experimentation 10 date desc Buja 1843 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22VPBG4MZ7%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Akkanti%20et%20al.%22%2C%22parsedDate%22%3A%222023-05-05%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAkkanti%2C%20B.%20H.%2C%20Hussain%2C%20R.%2C%20Patel%2C%20M.%20K.%20et%20al.%20%282023%29.%20Correction%3A%20Deadly%20combination%20of%20Vaping-lnduced%20lung%20injury%20and%20influenza%3A%20case%20report.%20%26lt%3Bi%26gt%3BDiagn%20Pathol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B18%26lt%3B%5C%2Fi%26gt%3B%2C%2058.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs13000-023-01345-5%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs13000-023-01345-5%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Correction%3A%20Deadly%20combination%20of%20Vaping-lnduced%20lung%20injury%20and%20influenza%3A%20case%20report%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bindu%20H.%22%2C%22lastName%22%3A%22Akkanti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rahat%22%2C%22lastName%22%3A%22Hussain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manish%20K.%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jayeshkumar%20A.%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kha%22%2C%22lastName%22%3A%22Dinh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bihong%22%2C%22lastName%22%3A%22Zhao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shaimaa%22%2C%22lastName%22%3A%22Elzamly%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%22%2C%22lastName%22%3A%22Pelicon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Klemen%22%2C%22lastName%22%3A%22Petek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ismael%20A.%20Salas%22%2C%22lastName%22%3A%22de%20Armas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mehmet%22%2C%22lastName%22%3A%22Akay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Biswajit%22%2C%22lastName%22%3A%22Kar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Igor%20D.%22%2C%22lastName%22%3A%22Gregoric%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20Maximilian%22%2C%22lastName%22%3A%22Buja%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222023-05-05%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs13000-023-01345-5%22%2C%22ISSN%22%3A%221746-1596%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22B3LYFWPU%22%2C%22Q46ISS7S%22%5D%2C%22dateModified%22%3A%222023-07-21T18%3A37%3A37Z%22%7D%7D%2C%7B%22key%22%3A%2225YLJ59K%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Maximilian%20Buja%22%2C%22parsedDate%22%3A%222023-01-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMaximilian%20%26lt%3Bstrong%26gt%3BBuja%26lt%3B%5C%2Fstrong%26gt%3B%2C%20L.%20%282023%29.%20In%20Memoriam%3A%20Tomas%20Klima%2C%20MD%20%281931-2022%29.%20%26lt%3Bi%26gt%3BTex%20Heart%20Inst%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B50%26lt%3B%5C%2Fi%26gt%3B%2C%20e228027.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-22-8027%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-22-8027%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22In%20Memoriam%3A%20Tomas%20Klima%2C%20MD%20%281931-2022%29%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Maximilian%20Buja%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222023-01-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.14503%5C%2FTHIJ-22-8027%22%2C%22ISSN%22%3A%221526-6702%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22B3LYFWPU%22%2C%22BNSCCUCI%22%5D%2C%22dateModified%22%3A%222023-06-08T13%3A52%3A32Z%22%7D%7D%2C%7B%22key%22%3A%22PWNND3BD%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kelly%20et%20al.%22%2C%22parsedDate%22%3A%222023%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKelly%2C%20K.%20L.%2C%20Lin%2C%20P.%20T.%2C%20Basso%2C%20C.%20et%20al.%20%282023%29.%20Sudden%20cardiac%20death%20in%20the%20young%3A%20A%20consensus%20statement%20on%20recommended%20practices%20for%20cardiac%20examination%20by%20pathologists%20from%20the%20Society%20for%20Cardiovascular%20Pathology.%20%26lt%3Bi%26gt%3BCardiovasc%20Pathol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B63%26lt%3B%5C%2Fi%26gt%3B%2C%20107497.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.carpath.2022.107497%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.carpath.2022.107497%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Sudden%20cardiac%20death%20in%20the%20young%3A%20A%20consensus%20statement%20on%20recommended%20practices%20for%20cardiac%20examination%20by%20pathologists%20from%20the%20Society%20for%20Cardiovascular%20Pathology%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%20L.%22%2C%22lastName%22%3A%22Kelly%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20T.%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cristina%22%2C%22lastName%22%3A%22Basso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melanie%22%2C%22lastName%22%3A%22Bois%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20Maximilian%22%2C%22lastName%22%3A%22Buja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20D.%22%2C%22lastName%22%3A%22Cohle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giulia%22%2C%22lastName%22%3A%22d%27Amati%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%22%2C%22lastName%22%3A%22Duncanson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20T.%22%2C%22lastName%22%3A%22Fallon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dennis%22%2C%22lastName%22%3A%22Firchau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%22%2C%22lastName%22%3A%22Fishbein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carla%22%2C%22lastName%22%3A%22Giordano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%22%2C%22lastName%22%3A%22Leduc%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Silvio%20H.%22%2C%22lastName%22%3A%22Litovsky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22Mackey-Bojack%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20J.%22%2C%22lastName%22%3A%22Maleszewski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katarzyna%22%2C%22lastName%22%3A%22Michaud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20F.%22%2C%22lastName%22%3A%22Padera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stavroula%20A.%22%2C%22lastName%22%3A%22Papadodima%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Parsons%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stanley%20J.%22%2C%22lastName%22%3A%22Radio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefania%22%2C%22lastName%22%3A%22Rizzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susan%20J.%22%2C%22lastName%22%3A%22Roe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%22%2C%22lastName%22%3A%22Romero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%20N.%22%2C%22lastName%22%3A%22Sheppard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20R.%22%2C%22lastName%22%3A%22Stone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carmela%20D.%22%2C%22lastName%22%3A%22Tan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gaetano%22%2C%22lastName%22%3A%22Thiene%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Allard%20C.%22%2C%22lastName%22%3A%22van%20der%20Wal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20P.%22%2C%22lastName%22%3A%22Veinot%22%7D%5D%2C%22abstractNote%22%3A%22Sudden%20cardiac%20death%20is%2C%20by%20definition%2C%20an%20unexpected%2C%20untimely%20death%20caused%20by%20a%20cardiac%20condition%20in%20a%20person%20with%20known%20or%20unknown%20heart%20disease.%20This%20major%20international%20public%20health%20problem%20accounts%20for%20approximately%2015-20%25%20of%20all%20deaths.%20Typically%20more%20common%20in%20older%20adults%20with%20acquired%20heart%20disease%2C%20SCD%20also%20can%20occur%20in%20the%20young%20where%20the%20cause%20is%20more%20likely%20to%20be%20a%20genetically%20transmitted%20process.%20As%20these%20inherited%20disease%20processes%20can%20affect%20multiple%20family%20members%2C%20it%20is%20critical%20that%20these%20deaths%20are%20appropriately%20and%20thoroughly%20investigated.%20Across%20the%20United%20States%2C%20SCD%20cases%20in%20those%20less%20than%2040%20years%20of%20age%20will%20often%20fall%20under%20medical%20examiner%5C%2Fcoroner%20jurisdiction%20resulting%20in%20scene%20investigation%2C%20review%20of%20available%20medical%20records%20and%20a%20complete%20autopsy%20including%20toxicological%20and%20histological%20studies.%20To%20date%2C%20there%20have%20not%20been%20consistent%20or%20uniform%20guidelines%20for%20cardiac%20examination%20in%20these%20cases.%20In%20addition%2C%20many%20medical%20examiner%5C%2Fcoroner%20offices%20are%20understaffed%20and%5C%2For%20underfunded%2C%20both%20of%20which%20may%20hamper%20specialized%20examinations%20or%20studies%20%28e.g.%2C%20molecular%20testing%29.%20Use%20of%20such%20guidelines%20by%20pathologists%20in%20cases%20of%20SCD%20in%20decedents%20aged%201-39%20years%20of%20age%20could%20result%20in%20life-saving%20medical%20intervention%20for%20other%20family%20members.%20These%20recommendations%20also%20may%20provide%20support%20for%20underfunded%20offices%20to%20argue%20for%20the%20significance%20of%20this%20specialized%20testing.%20As%20cardiac%20examinations%20in%20the%20setting%20of%20SCD%20in%20the%20young%20fall%20under%20ME%5C%2FC%20jurisdiction%2C%20this%20consensus%20paper%20has%20been%20developed%20with%20members%20of%20the%20Society%20of%20Cardiovascular%20Pathology%20working%20with%20cardiovascular%20pathology-trained%2C%20practicing%20forensic%20pathologists.%22%2C%22date%22%3A%222023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.carpath.2022.107497%22%2C%22ISSN%22%3A%221879-1336%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22B3LYFWPU%22%2C%22FA6KSIY7%22%5D%2C%22dateModified%22%3A%222023-02-14T15%3A21%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22VDUW7QHE%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jyothula%20et%20al.%22%2C%22parsedDate%22%3A%222022-12%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BJyothula%2C%20S.%20S.%20K.%2C%20Peters%2C%20A.%2C%20Liang%2C%20Y.%20et%20al.%20%282022%29.%20Fulminant%20lung%20fibrosis%20in%20non-resolvable%20COVID-19%20requiring%20transplantation.%20%26lt%3Bi%26gt%3BEBioMedicine%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B86%26lt%3B%5C%2Fi%26gt%3B%2C%20104351.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ebiom.2022.104351%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ebiom.2022.104351%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Fulminant%20lung%20fibrosis%20in%20non-resolvable%20COVID-19%20requiring%20transplantation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Soma%20S.%20K.%22%2C%22lastName%22%3A%22Jyothula%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Peters%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yafen%22%2C%22lastName%22%3A%22Liang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Weizhen%22%2C%22lastName%22%3A%22Bi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pooja%22%2C%22lastName%22%3A%22Shivshankar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%22%2C%22lastName%22%3A%22Yau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Puneet%20S.%22%2C%22lastName%22%3A%22Garcha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaoyi%22%2C%22lastName%22%3A%22Yuan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bindu%22%2C%22lastName%22%3A%22Akkanti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%22%2C%22lastName%22%3A%22Collum%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nancy%22%2C%22lastName%22%3A%22Wareing%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rajarajan%20A.%22%2C%22lastName%22%3A%22Thandavarayan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Poli%20de%20Frias%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ivan%20O.%22%2C%22lastName%22%3A%22Rosas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bihong%22%2C%22lastName%22%3A%22Zhao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20Maximilian%22%2C%22lastName%22%3A%22Buja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Holger%20K.%22%2C%22lastName%22%3A%22Eltzschig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Howard%20J.%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harry%22%2C%22lastName%22%3A%22Karmouty-Quintana%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Coronavirus%20Disease%202019%20%28COVID-19%29%20can%20lead%20to%20the%20development%20of%20acute%20respiratory%20distress%20syndrome%20%28ARDS%29.%20In%20some%20patients%20with%20non-resolvable%20%28NR%29%20COVID-19%2C%20lung%20injury%20can%20progress%20rapidly%20to%20the%20point%20that%20lung%20transplantation%20is%20the%20only%20viable%20option%20for%20survival.%20This%20fatal%20progression%20of%20lung%20injury%20involves%20a%20rapid%20fibroproliferative%20response%20and%20takes%20on%20average%2015%20weeks%20from%20initial%20symptom%20presentation.%20Little%20is%20known%20about%20the%20mechanisms%20that%20lead%20to%20this%20fulminant%20lung%20fibrosis%20%28FLF%29%20in%20NR-COVID-19.%5CnMETHODS%3A%20Using%20a%20pre-designed%20unbiased%20PCR%20array%20for%20fibrotic%20markers%2C%20we%20analyzed%20the%20fibrotic%20signature%20in%20a%20subset%20of%20NR-COVID-19%20lungs.%20We%20compared%20the%20expression%20profile%20against%20control%20lungs%20%28donor%20lungs%20discarded%20for%20transplantation%29%2C%20and%20explanted%20tissue%20from%20patients%20with%20idiopathic%20pulmonary%20fibrosis%20%28IPF%29.%20Subsequently%2C%20RT-qPCR%2C%20Western%20blots%20and%20immunohistochemistry%20were%20conducted%20to%20validate%20and%20localize%20selected%20pro-fibrotic%20targets.%20A%20total%20of%2023%20NR-COVID-19%20lungs%20were%20used%20for%20RT-qPCR%20validation.%5CnFINDINGS%3A%20We%20revealed%20a%20unique%20fibrotic%20gene%20signature%20in%20NR-COVID-19%20that%20is%20dominated%20by%20a%20hyper-expression%20of%20pro-fibrotic%20genes%2C%20including%20collagens%20and%20periostin.%20Our%20results%20also%20show%20a%20significantly%20increased%20expression%20of%20Collagen%20Triple%20Helix%20Repeat%20Containing%201%28CTHRC1%29%20which%20co-localized%20in%20areas%20rich%20in%20alpha%20smooth%20muscle%20expression%2C%20denoting%20myofibroblasts.%20We%20also%20show%20a%20significant%20increase%20in%20cytokeratin%20%28KRT%29%205%20and%208%20expressing%20cells%20adjacent%20to%20fibroblastic%20areas%20and%20in%20areas%20of%20apparent%20epithelial%20bronchiolization.%5CnINTERPRETATION%3A%20Our%20studies%20may%20provide%20insights%20into%20potential%20cellular%20mechanisms%20that%20lead%20to%20a%20fulminant%20presentation%20of%20lung%20fibrosis%20in%20NR-COVID-19.%5CnFUNDING%3A%20National%20Institute%20of%20Health%20%28NIH%29%20Grants%20R01HL154720%2C%20R01DK122796%2C%20R01DK109574%2C%20R01HL133900%2C%20and%20Department%20of%20Defense%20%28DoD%29%20Grant%20W81XWH2110032%20to%20H.K.E.%20NIH%20Grants%3A%20R01HL138510%20and%20R01HL157100%2C%20DoD%20Grant%20W81XWH-19-1-0007%2C%20and%20American%20Heart%20Association%20Grant%3A%2018IPA34170220%20to%20H.K.-Q.%20American%20Heart%20Association%3A%2019CDA34660279%2C%20American%20Lung%20Association%3A%20CA-622265%2C%20Parker%20B.%20Francis%20Fellowship%2C%201UL1TR003167-01%20and%20The%20Center%20for%20Clinical%20and%20Translational%20Sciences%2C%20McGovern%20Medical%20School%20to%20X.Y.%22%2C%22date%22%3A%22Dec%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ebiom.2022.104351%22%2C%22ISSN%22%3A%222352-3964%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22B3LYFWPU%22%2C%22TXW6RMW4%22%5D%2C%22dateModified%22%3A%222023-01-06T17%3A13%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22KASSZL6Z%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Salas%20De%20Armas%20et%20al.%22%2C%22parsedDate%22%3A%222022-11-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSalas%20De%20Armas%2C%20I.%20A.%2C%20%26lt%3Bstrong%26gt%3BBuja%26lt%3B%5C%2Fstrong%26gt%3B%2C%20L.%20M.%2C%20Patel%2C%20M.%20K.%20et%20al.%20%282022%29.%20Aortic%20root%20dissection%20due%20to%20an%20automated%20fastener%20device.%20%26lt%3Bi%26gt%3BTex%20Heart%20Inst%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B49%26lt%3B%5C%2Fi%26gt%3B%2C%20e207531.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-20-7531%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-20-7531%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Aortic%20root%20dissection%20due%20to%20an%20automated%20fastener%20device%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ismael%20A.%22%2C%22lastName%22%3A%22Salas%20De%20Armas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20Maximilian%22%2C%22lastName%22%3A%22Buja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manish%20K.%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jayeshkumar%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mehmet%20H.%22%2C%22lastName%22%3A%22Akay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emre%22%2C%22lastName%22%3A%22Gok%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Igor%20D.%22%2C%22lastName%22%3A%22Gregoric%22%7D%5D%2C%22abstractNote%22%3A%22Minimally%20invasive%20aortic%20valve%20replacement%20through%20a%20right%20thoracotomy%20is%20frequently%20performed%20in%20patients%20with%20aortic%20valve%20disease.%20The%20Cor-Knot%20Device%20%28LSI%20Solutions%29%20is%20an%20automated%20fastener%20that%20secures%20valve%20sutures.%20This%20case%20report%20is%20for%20a%20patient%20who%20developed%20postcardiotomy%20shock%20during%20a%20minimally%20invasive%20aortic%20valve%20surgery.%20The%20patient%20was%20found%20to%20have%20an%20aortic%20root%20dissection%20involving%2090%25%20of%20the%20aortic%20root%20circumference%2C%20including%20bilateral%20coronary%20ostia.%20The%20autopsy%20revealed%20that%20the%20aortic%20damage%20could%20be%20explained%20by%20a%20direct%20aortic%20intimal%20tear%20from%20the%20distal%20tip%20of%20the%20device%20shaft.%20The%20device%20was%20most%20likely%20not%20in%20perfect%20apposition%20to%20the%20sewing%20ring%20because%20of%20the%20restricted%20angle%20and%20space%20between%20the%20ribs.%22%2C%22date%22%3A%22Nov%2001%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.14503%5C%2FTHIJ-20-7531%22%2C%22ISSN%22%3A%221526-6702%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22B3LYFWPU%22%2C%22FA6KSIY7%22%5D%2C%22dateModified%22%3A%222023-02-14T20%3A18%3A13Z%22%7D%7D%2C%7B%22key%22%3A%22ZGNUPFBK%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lu%20et%20al.%22%2C%22parsedDate%22%3A%222022-10-06%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLu%2C%20G.%2C%20Zhu%2C%20P.%2C%20Rao%2C%20M.%20et%20al.%20%282022%29.%20Postmortem%20study%20of%20organ-specific%20toxicity%20in%20glioblastoma%20patients%20treated%20with%20a%20combination%20of%20temozolomide%2C%20irinotecan%20and%20bevacizumab.%20%26lt%3Bi%26gt%3BJ%20Neurooncol%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs11060-022-04144-y%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs11060-022-04144-y%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Postmortem%20study%20of%20organ-specific%20toxicity%20in%20glioblastoma%20patients%20treated%20with%20a%20combination%20of%20temozolomide%2C%20irinotecan%20and%20bevacizumab%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guangrong%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ping%22%2C%22lastName%22%3A%22Zhu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mayank%22%2C%22lastName%22%3A%22Rao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nadine%22%2C%22lastName%22%3A%22Linendoll%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20Maximilian%22%2C%22lastName%22%3A%22Buja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meenakshi%20B.%22%2C%22lastName%22%3A%22Bhattacharjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20E.%22%2C%22lastName%22%3A%22Brown%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leomar%20Y.%22%2C%22lastName%22%3A%22Ballester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xuejun%22%2C%22lastName%22%3A%22Tian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Monika%22%2C%22lastName%22%3A%22Pilichowska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julian%20K.%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Georgene%20W.%22%2C%22lastName%22%3A%22Hergenroeder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Williams%20F.%22%2C%22lastName%22%3A%22Glass%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lei%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rongzhen%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anil%20K.%22%2C%22lastName%22%3A%22Pillai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20L.%22%2C%22lastName%22%3A%22Hunter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jay-Jiguang%22%2C%22lastName%22%3A%22Zhu%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20Systemic%20chemotherapy%20including%5Cu00a0monotherapy%20with%20temozolomide%20%28TMZ%29%20or%20bevacizumab%20%28BEV%29%3B%20two-drug%20combinations%2C%20such%20as%20irinotecan%20%28IRI%29%20and%20BEV%2C%20TMZ%20and%20BEV%20and%20a%20three-drug%20combination%20with%20TMZ%2C%20IRI%20and%20BEV%20%28TIB%29%20have%20been%20used%20in%20treating%20patients%20with%20progressive%20high-grade%20gliomas%20including%20glioblastoma%20%28GBM%29.%20Most%20patients%20tolerated%20these%20regimens%20well%20with%20known%20side%20effects%20of%20hypertension%2C%20proteinuria%2C%20and%20reversible%20clinical%20myelosuppression%20%28CM%29.%20However%2C%20organ-%20or%20system-%20specific%20toxicities%20from%20chemotherapy%20agents%20have%20never%20been%20examined%20by%20postmortem%20study.%20This%20is%20the%20largest%20cohort%20used%20to%20address%20this%20issue%20in%20glioma%20patients.%5CnMETHODS%3A%20Postmortem%20tissues%20%28from%20all%20major%20systems%20and%20organs%29%20were%20prospectively%20collected%20and%20examined%20by%20standard%20institution%20autopsy%5Cu00a0and%20neuropathological%5Cu00a0procedures%5Cu00a0from%2076%20subjects%2C%20including%20gliomas%20%28N%5Cu2009%3D%5Cu200968%2C%2044%5C%2FM%2C%20and%2024%5C%2FF%29%20and%20brain%20metastases%20%28N%5Cu2009%3D%5Cu20098%2C%205%5C%2FM%2C%20and%203%5C%2FF%29%20between%202009%20and%202019.%20Standard%20hematoxylin%20and%20eosin%5Cu00a0%28H%26amp%3BE%29%20were%20performed%20on%20all%20major%20organs%20including%20brain%20specimens.%5Cu00a0Electronic%20microscopic%5Cu00a0%28EM%29%20study%20was%20carried%20out%20on%2014%20selected%20subject%26%23039%3Bs%20kidney%20samples%20per%20standard%20EM%20protocol.%20Medical%20records%20were%20reviewed%20with%20adverse%20events%20%28AEs%29%20analyzed%20and%20graded%20according%20to%20the%20Common%20Terminology%20Criteria%20for%20Adverse%20Events%20%28CTCAE%29%2C%20version%204.03.%20A%20swimmer%20plot%20was%20utilized%20to%20visualize%20the%20timelines%20of%20patient%20history%20by%20treatment%20group.%20The%20binary%20logistic%20regression%20models%20were%20performed%20to%20explore%20any%20associations%20between%20treatment%20strategies%20and%20incident%20myelosuppression.%5CnRESULTS%3A%20Twenty-four%20glioma%20subjects%20were%20treated%20with%20TIB%20%5Bmedian%3A%205.5%20%28range%3A%201-25%29%20cycles%5D%20at%20tumor%20recurrence.%5Cu00a0Exposure%20to%20IRI%20significantly%20increased%20the%20frequency%20of%20CM%20%28p%5Cu2009%3D%5Cu20090.05%29.%20No%20unexpected%20adverse%20events%20clinically%2C%20or%20permanent%20end-organ%20damage%20during%20postmortem%20examination%20was%20identified%20in%20glioma%5Cu00a0subjects%20who%20had%20received%20standard%20or%20prolonged%20duration%20of%20BEV%2C%20TMZ%20or%20TIB%20regimen-based%20chemotherapies%20except%20rare%20events%20of%20bone%20marrow%20suppression.%5Cu00a0The%20most%20common%20causes%20of%20death%20%28COD%29%20were%20tumor%20progression%20%2863.2%25%2C%20N%5Cu2009%3D%5Cu200943%29%20followed%20by%20aspiration%20pneumonia%20%2848.5%25%2C%20N%5Cu2009%3D%5Cu200933%29%20in%20glioma%20subjects.%20No%20COD%20was%20attributed%20to%20acute%20toxicity%20from%20TIB.%20The%20study%20also%20demonstrated%20that%20postmortem%20kidney%20specimen%20is%20unsuitable%20for%20studying%20renal%20ultrastructural%20pathological%20changes%20due%20to%20autolysis.%5CnCONCLUSION%3A%20There%20is%20no%20organ%20or%20system%20toxicity%20by%20postmortem%20examinations%20among%20glioma%20subjects%20who%20received%20BEV%2C%20TMZ%20or%20TIB%20regimen-based%20chemotherapies%20regardless%20of%20durations%20except%20for%20occasional%20bone%20marrow%20suppression%20and%20reversible%20myelosuppression%20clinically.%5Cu00a0IRI%2C%20but%20not%20the%20extended%20use%20of%20TMZ%2C%20significantly%20increased%20CM%20in%20recurrent%20glioma%20patients.%20COD%20most%20commonly%20resulted%20from%20glioma%20tumor%20progression%20with%20infiltration%20to%20brain%20stem%20and%20aspiration%20pneumonia.%22%2C%22date%22%3A%22Oct%2006%2C%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs11060-022-04144-y%22%2C%22ISSN%22%3A%221573-7373%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22B3LYFWPU%22%2C%22MDTREPAF%22%5D%2C%22dateModified%22%3A%222022-11-04T15%3A29%3A18Z%22%7D%7D%2C%7B%22key%22%3A%22ZK7UNLG9%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22da%20Gra%5Cu00e7a%20Cabreira%20et%20al.%22%2C%22parsedDate%22%3A%222022-09-12%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3Bda%20Gra%26%23xE7%3Ba%20Cabreira%2C%20M.%2C%20Wang%2C%20X.%2C%20Critsinelis%2C%20A.%20et%20al.%20%282022%29.%20Environmental%20oxygen%20affects%20ex%20vivo%20growth%20and%20proliferation%20of%20mesenchymal%20progenitors%20by%20modulating%20mitogen-activated%20protein%20kinase%20and%20mammalian%20target%20of%20rapamycin%20signaling.%20%26lt%3Bi%26gt%3BCytotherapy%26lt%3B%5C%2Fi%26gt%3B%2C%20S1465-3249%2822%2900707%26%23x2013%3B1.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jcyt.2022.06.005%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jcyt.2022.06.005%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Environmental%20oxygen%20affects%20ex%20vivo%20growth%20and%20proliferation%20of%20mesenchymal%20progenitors%20by%20modulating%20mitogen-activated%20protein%20kinase%20and%20mammalian%20target%20of%20rapamycin%20signaling%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%22%2C%22lastName%22%3A%22da%20Gra%5Cu00e7a%20Cabreira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaohong%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andre%22%2C%22lastName%22%3A%22Critsinelis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mekedlawit%22%2C%22lastName%22%3A%22Setegne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Parisa%22%2C%22lastName%22%3A%22Lotfi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ying-Wooi%22%2C%22lastName%22%3A%22Wan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriela%22%2C%22lastName%22%3A%22Barrios%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhuyong%22%2C%22lastName%22%3A%22Mei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrian%20P.%22%2C%22lastName%22%3A%22Gee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Louis%20Maximilian%22%2C%22lastName%22%3A%22Buja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emerson%22%2C%22lastName%22%3A%22Perin%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%20AIMS%3A%20Stem%20and%20progenitor%20cells%20of%20hematopoietic%20and%20mesenchymal%20lineages%20reside%20in%20the%20bone%20marrow%20under%20low%20oxygen%20%28O2%29%20saturation.%20O2%20levels%20used%20in%20ex%20vivo%20expansion%20of%20multipotent%20mesenchymal%20stromal%20cells%20%28MSCs%29%20affect%20proliferation%2C%20metabolism%20and%20differentiation.%5CnMETHODS%3A%20Using%20cell-based%20assays%20and%20transcriptome%20and%20proteome%20data%2C%20the%20authors%20compared%20MSC%20cultures%20simultaneously%20grown%20under%20a%20conventional%2019.95%25%20O2%20atmosphere%20or%20at%205%25%20O2.%5CnRESULTS%3A%20In%205%25%20O2%2C%20MSCs%20showed%20better%20proliferation%20and%20higher%20self-renewal%20ability%2C%20most%20probably%20sustained%20by%20enhanced%20signaling%20activity%20of%20mitogen-activated%20protein%20kinase%20and%20mammalian%20target%20of%20rapamycin%20pathways.%20Non-oxidative%20glycolysis-based%20energy%20metabolism%20supported%20growth%20and%20proliferation%20in%205%25%20O2%20cultures%2C%20whereas%20MSCs%20grown%20under%2019.95%25%20O2%20also%20utilized%20oxidative%20phosphorylation.%20Cytoprotection%20mechanisms%20used%20by%20cells%20under%205%25%20O2%5Cu00a0differed%20from%2019.95%25%20O2%5Cu00a0%20suggesting%20differences%20in%20the%20triggers%20of%20cell%20stress%20between%20these%20two%20O2%5Cu00a0%20conditions.%5CnCONCLUSIONS%3A%20Based%20on%20the%20potential%20benefits%20for%20the%20growth%20and%20metabolism%20of%20MSCs%2C%20the%20authors%20propose%20the%20use%20of%205%25%20O2%20for%20MSC%20culture.%22%2C%22date%22%3A%22Sept%2012%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jcyt.2022.06.005%22%2C%22ISSN%22%3A%221477-2566%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22B3LYFWPU%22%2C%228HHBIBI6%22%2C%22JK8LVZ9C%22%2C%228PULYTSK%22%2C%22C27MTI39%22%5D%2C%22dateModified%22%3A%222022-10-05T15%3A44%3A52Z%22%7D%7D%2C%7B%22key%22%3A%22NE5QFWVJ%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Yohannan%20et%20al.%22%2C%22parsedDate%22%3A%222022-08%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BYohannan%2C%20B.%2C%20Rios%2C%20A.%20and%20%26lt%3Bstrong%26gt%3BBuja%26lt%3B%5C%2Fstrong%26gt%3B%2C%20M.%20%282022%29.%20Durable%20remission%20in%20hodgkin%20lymphoma%20treated%20with%20one%20cycle%20of%20bleomycin%2C%20vinblastine%2C%20dacarbazine%20and%20two%20doses%20of%20nivolumab%20and%20brentuximab%20vedotin.%20%26lt%3Bi%26gt%3BJ%20Hematol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B11%26lt%3B%5C%2Fi%26gt%3B%2C%20154%26%23x2013%3B158.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14740%5C%2Fjh1035%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14740%5C%2Fjh1035%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Durable%20remission%20in%20hodgkin%20lymphoma%20treated%20with%20one%20cycle%20of%20bleomycin%2C%20vinblastine%2C%20dacarbazine%20and%20two%20doses%20of%20nivolumab%20and%20brentuximab%20vedotin%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Binoy%22%2C%22lastName%22%3A%22Yohannan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adan%22%2C%22lastName%22%3A%22Rios%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maximilian%22%2C%22lastName%22%3A%22Buja%22%7D%5D%2C%22abstractNote%22%3A%22A%2049-year-old%20woman%20with%20systemic%20lupus%20erythematosus%2C%20lupus%20nephritis%20and%20chronic%20congestive%20heart%20failure%20presenting%20with%20%26quot%3Bbulky%26quot%3B%20cervical%20lymphadenopathy%20was%20diagnosed%20with%20classic%20Hodgkin%20lymphoma%20%28HL%29%20stage%20IIIB%20%28positron%20emission%20tomography-computed%20tomography%20%28PET-CT%29%20scan%20and%20bone%20marrow%20biopsy%29.%20She%20received%20one%20cycle%20of%20bleomycin%2C%20dacarbazine%2C%20and%20vinblastine%20to%20debulk%20the%20tumor.%20Given%20her%20advanced%20heart%20failure%2C%20doxorubicin%20was%20not%20administered.%20After%20the%20first%20cycle%20of%20chemotherapy%2C%20she%20was%20switched%20to%20nivolumab%20plus%20brentuximab%20vedotin%20%28BV%29%20and%20received%20two%20doses%204%20weeks%20apart%2C%20finishing%20in%20July%202019.%20A%20restaging%20PET-CT%20in%20June%202019%20showed%20a%20complete%20remission%20%28CR%29.%20After%20the%20second%20course%20of%20treatment%2C%20she%20was%20unable%20to%20tolerate%20more%20treatments%20and%20hence%20was%20placed%20on%20a%20surveillance%20program.%20She%20remains%20in%20CR%20after%20a%20follow-up%20of%203%20years.%20This%20case%20highlights%20the%20role%20of%20a%20tailored%20treatment%20approach%20to%20optimize%20clinical%20outcomes%20in%20uniquely%20complex%20clinical%20circumstances.%20BV%20in%20combination%20with%20nivolumab%20is%20a%20reasonable%20alternative%20regimen%20in%20HL%20ineligible%20for%20cytotoxic%20chemotherapy.%22%2C%22date%22%3A%22Aug%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.14740%5C%2Fjh1035%22%2C%22ISSN%22%3A%221927-1220%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22B3LYFWPU%22%2C%22C27MTI39%22%5D%2C%22dateModified%22%3A%222022-10-05T15%3A44%3A17Z%22%7D%7D%2C%7B%22key%22%3A%228CG7NC6K%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Achim%20et%20al.%22%2C%22parsedDate%22%3A%222022-06-26%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAchim%2C%20A.%2C%20Savaria%2C%20B.%20U.%20and%20%26lt%3Bstrong%26gt%3BBuja%26lt%3B%5C%2Fstrong%26gt%3B%2C%20L.%20M.%20%282022%29.%20Commentary%20on%20the%20enigma%20of%20small%20vessel%20disease%20in%20hypertrophic%20cardiomyopathy%3A%20is%20invasive%20assessment%20of%20microvascular%20resistance%20a%20novel%20independent%20predictor%20of%20prognosis%3F%20%26lt%3Bi%26gt%3BCardiovasc%20Pathol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B60%26lt%3B%5C%2Fi%26gt%3B%2C%20107448.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.carpath.2022.107448%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.carpath.2022.107448%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Commentary%20on%20the%20enigma%20of%20small%20vessel%20disease%20in%20hypertrophic%20cardiomyopathy%3A%20is%20invasive%20assessment%20of%20microvascular%20resistance%20a%20novel%20independent%20predictor%20of%20prognosis%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandru%22%2C%22lastName%22%3A%22Achim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Badal%20U.%22%2C%22lastName%22%3A%22Savaria%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20Maximilian%22%2C%22lastName%22%3A%22Buja%22%7D%5D%2C%22abstractNote%22%3A%22The%20key%20pathophysiological%20features%20in%20hypertrophic%20cardiomyopathy%20are%20ventricular%20hypertrophy%2C%20diastolic%20dysfunction%2C%20and%20abnormalities%20in%20the%20mitral%20valve%20apparatus%2C%20but%20coronary%20microvascular%20dysfunction%20and%20ischemia%20have%20also%20been%20described.%20The%20small%20vessel%20disease%20changes%20could%20be%20reflected%20in%20the%20invasive%20measurement%20of%20the%20index%20of%20microvascular%20resistance%2C%20with%20prognostic%20potential.%22%2C%22date%22%3A%22June%2026%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.carpath.2022.107448%22%2C%22ISSN%22%3A%221879-1336%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22B3LYFWPU%22%2C%222RCWVZ4F%22%5D%2C%22dateModified%22%3A%222022-08-02T14%3A39%3A39Z%22%7D%7D%2C%7B%22key%22%3A%22VANIX2CS%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chattopadhyay%20et%20al.%22%2C%22parsedDate%22%3A%222022-06-16%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BChattopadhyay%2C%20A.%2C%20Guan%2C%20P.%2C%20Majumder%2C%20S.%20et%20al.%20%282022%29.%20Preventing%20cholesterol-induced%20perk%20%28protein%20kinase%20rna-like%20endoplasmic%20reticulum%20kinase%29%20signaling%20in%20smooth%20muscle%20cells%20blocks%20atherosclerotic%20plaque%20formation.%20%26lt%3Bi%26gt%3BArterioscler%20Thromb%20Vasc%20Biol%26lt%3B%5C%2Fi%26gt%3B%2C%20101161ATVBAHA121317451.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FATVBAHA.121.317451%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FATVBAHA.121.317451%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Preventing%20cholesterol-induced%20perk%20%28protein%20kinase%20rna-like%20endoplasmic%20reticulum%20kinase%29%20signaling%20in%20smooth%20muscle%20cells%20blocks%20atherosclerotic%20plaque%20formation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abhijnan%22%2C%22lastName%22%3A%22Chattopadhyay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pujun%22%2C%22lastName%22%3A%22Guan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suravi%22%2C%22lastName%22%3A%22Majumder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaveeta%22%2C%22lastName%22%3A%22Kaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhen%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chen%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Siddharth%20K.%22%2C%22lastName%22%3A%22Prakash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anita%22%2C%22lastName%22%3A%22Kaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20Maximillian%22%2C%22lastName%22%3A%22Buja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Callie%20S.%22%2C%22lastName%22%3A%22Kwartler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dianna%20M.%22%2C%22lastName%22%3A%22Milewicz%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Vascular%20smooth%20muscle%20cells%20%28SMCs%29%20undergo%20complex%20phenotypic%20modulation%20with%20atherosclerotic%20plaque%20formation%20in%20hyperlipidemic%20mice%2C%20which%20is%20characterized%20by%20de-differentiation%20and%20heterogeneous%20increases%20in%20the%20expression%20of%20macrophage%2C%20fibroblast%2C%20osteogenic%2C%20and%20stem%20cell%20markers.%20An%20increase%20of%20cellular%20cholesterol%20in%20SMCs%20triggers%20similar%20phenotypic%20changes%20in%20vitro%20with%20exposure%20to%20free%20cholesterol%20due%20to%20cholesterol%20entering%20the%20endoplasmic%20reticulum%2C%20triggering%20endoplasmic%20reticulum%20stress%20and%20activating%20Perk%20%28protein%20kinase%20RNA-like%20endoplasmic%20reticulum%20kinase%29%20signaling.%5CnMETHODS%3A%20We%20generated%20an%20SMC-specific%20Perk%20knockout%20mouse%20model%2C%20induced%20hyperlipidemia%20in%20the%20mice%20by%20AAV-PCSK9DY%20injection%2C%20and%20subjected%20them%20to%20a%20high-fat%20diet.%20We%20then%20assessed%20atherosclerotic%20plaque%20formation%20and%20performed%20single-cell%20transcriptomic%20studies%20using%20aortic%20tissue%20from%20these%20mice.%5CnRESULTS%3A%20SMC-specific%20deletion%20of%20Perk%20reduces%20atherosclerotic%20plaque%20formation%20in%20male%20hyperlipidemic%20mice%20by%2080%25.%20Single-cell%20transcriptomic%20data%20identify%202%20clusters%20of%20modulated%20SMCs%20in%20hyperlipidemic%20mice%2C%20one%20of%20which%20is%20absent%20when%20Perk%20is%20deleted%20in%20SMCs.%20The%202%20modulated%20SMC%20clusters%20have%20significant%20overlap%20of%20transcriptional%20changes%2C%20but%20the%20Perk-dependent%20cluster%20uniquely%20shows%20a%20global%20decrease%20in%20the%20number%20of%20transcripts%2C%20a%20marker%20of%20an%20integrated%20stress%20response.%20SMC-specific%20Perk%20deletion%20also%20prevents%20migration%20of%20both%20contractile%20and%20modulated%20SMCs%20from%20the%20medial%20layer%20of%20the%20aorta.%5CnCONCLUSIONS%3A%20Our%20results%20indicate%20that%20hypercholesterolemia%20drives%20both%20Perk-dependent%20and%20Perk-independent%20SMC%20modulation%20and%20that%20deficiency%20of%20Perk%20significantly%20blocks%20atherosclerotic%20plaque%20formation.%22%2C%22date%22%3A%22June%2016%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1161%5C%2FATVBAHA.121.317451%22%2C%22ISSN%22%3A%221524-4636%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22B3LYFWPU%22%2C%22AQAKSSWQ%22%2C%22ZSY78DJL%22%5D%2C%22dateModified%22%3A%222022-07-06T19%3A05%3A45Z%22%7D%7D%5D%7D
Akkanti, B. H., Hussain, R., Patel, M. K. et al. (2023). Correction: Deadly combination of Vaping-lnduced lung injury and influenza: case report. Diagn Pathol 18, 58. https://doi.org/10.1186/s13000-023-01345-5.
Maximilian Buja, L. (2023). In Memoriam: Tomas Klima, MD (1931-2022). Tex Heart Inst J 50, e228027. https://doi.org/10.14503/THIJ-22-8027.
Kelly, K. L., Lin, P. T., Basso, C. et al. (2023). Sudden cardiac death in the young: A consensus statement on recommended practices for cardiac examination by pathologists from the Society for Cardiovascular Pathology. Cardiovasc Pathol 63, 107497. https://doi.org/10.1016/j.carpath.2022.107497.
Jyothula, S. S. K., Peters, A., Liang, Y. et al. (2022). Fulminant lung fibrosis in non-resolvable COVID-19 requiring transplantation. EBioMedicine 86, 104351. https://doi.org/10.1016/j.ebiom.2022.104351.
Salas De Armas, I. A., Buja, L. M., Patel, M. K. et al. (2022). Aortic root dissection due to an automated fastener device. Tex Heart Inst J 49, e207531. https://doi.org/10.14503/THIJ-20-7531.
Lu, G., Zhu, P., Rao, M. et al. (2022). Postmortem study of organ-specific toxicity in glioblastoma patients treated with a combination of temozolomide, irinotecan and bevacizumab. J Neurooncol. https://doi.org/10.1007/s11060-022-04144-y.
da Graça Cabreira, M., Wang, X., Critsinelis, A. et al. (2022). Environmental oxygen affects ex vivo growth and proliferation of mesenchymal progenitors by modulating mitogen-activated protein kinase and mammalian target of rapamycin signaling. Cytotherapy, S1465-3249(22)00707–1. https://doi.org/10.1016/j.jcyt.2022.06.005.
Yohannan, B., Rios, A. and Buja, M. (2022). Durable remission in hodgkin lymphoma treated with one cycle of bleomycin, vinblastine, dacarbazine and two doses of nivolumab and brentuximab vedotin. J Hematol 11, 154–158. https://doi.org/10.14740/jh1035.
Achim, A., Savaria, B. U. and Buja, L. M. (2022). Commentary on the enigma of small vessel disease in hypertrophic cardiomyopathy: is invasive assessment of microvascular resistance a novel independent predictor of prognosis? Cardiovasc Pathol 60, 107448. https://doi.org/10.1016/j.carpath.2022.107448.
Chattopadhyay, A., Guan, P., Majumder, S. et al. (2022). Preventing cholesterol-induced perk (protein kinase rna-like endoplasmic reticulum kinase) signaling in smooth muscle cells blocks atherosclerotic plaque formation. Arterioscler Thromb Vasc Biol, 101161ATVBAHA121317451. https://doi.org/10.1161/ATVBAHA.121.317451.